David Weiner | Executive Vice President and Director of Vaccine and Immunotherapy Center
The Wistar Institute

David Weiner, Executive Vice President and Director of Vaccine and Immunotherapy Center, The Wistar Institute

David B. Weiner, Ph.D.
Executive Vice President, The Wistar Institute
Director, Vaccine & Immunotherapy Center
Professor & WW Smith Distinguished Chair in Cancer Research 
Professor Emeritus, University of Pennsylvania - SOM
The Wistar Institute
3601 Spruce Street, Philadelphia PA 19104 T: 215-898-3986   Brief Bio: Dr. Weiner directs a translational molecular immunology research group focused on synthetic nucleic acid approaches for disease prevention and treatment.  His early work developed mAb targeting tumor antigens as well as viruses.  His group went on to be one of the founding research teams in the field of Nucleic Acid Vaccines and Immune therapies.  With collaborators he developed a pathway to the clinic enabling the first DNA vaccine trails for infectious diseases and for Cancer immune-therapy therefore opening up clinical approaches for other nucleic acid vaccines.   Using cutting edge antigen design with a focus on invivo assembly + modifications of delivery, these studies has helped expand multiple clinical nucleic acid vaccine studies including advancing countermeasures for Emerging infectious Diseases, and development of novel gene based approaches for therapy of cancer, as well as advancing genetic approaches for delivery of mAb.     Dr. Weiner’s resume includes publication of over 510 papers/chapters & reviews and he has provided over 850 lectures. He has received several awards/honors, including the WW Smith Family Chair in Cancer Research - 2016, Vaccine Industry Association Outstanding Academic Research Laboratory (2015 & 2016) (runner up 2017, 2018, 2019), Named Top 20 Translational Research Laboratories of the Year (Nature Biotechnology 2016 , 2017, 2018, 2019 & 2020), the Stone family award for Cancer Research 2014, An NIH Directors Translational Research Award- 2011, the Pennsylvania Life Sciences Achievement Award (2019), the Pennsylvania Drug Industry Award for Excellence (2022), the Genescript outstanding lab award 2023.  

Appearances:



Day 2 - Wednesday 3rd April @ 17:55

Self-assembling in-vivo nano particle vaccines

last published: 28/Mar/24 14:25 GMT

back to speakers